Low-flow oxygen and bilevel ventilatory support: effects on ventilation during sleep in cystic fibrosis.
We measured ventilation in all sleep stages in patients with cystic fibrosis (CF) and moderate to severe lung disease, and compared the effects of low-flow oxygen (LFO2) and bilevel ventilatory support (BVS) on ventilation and gas exchange during sleep. Thirteen subjects, age 26 +/- 5.9 yr (mean +/- 1 SD), body mass index (BMI) 20 +/- 3 kg/m2, FEV1 32 +/- 11% predicted, underwent three sleep studies breathing, in random order, room air (RA), LFO2, and BVS +/- O2 with recording of oxyhemoglobin saturation (SpO2) (%) and transcutaneous carbon dioxide (TcCO2) (mm Hg). During RA and LFO2 studies, patients wore a nasal mask with a baseline continuous positive airway pressure (CPAP) of 4 to 5 cm H2O. Minute ventilation (V I) was measured using a pneumotachograph in the circuit and was not different between wake and non-rapid eye movement (NREM) sleep on any night. However, V I was reduced on the RA and LFO2 nights from awake to rapid eye movement (REM) (p < 0.01) and from NREM to REM (p < 0.01). On the BVS night there was no significant difference in V I between NREM and REM sleep. Both BVS and LFO2 improved nocturnal SpO2, especially during REM sleep (p < 0.05). The rise in TcCO2 seen with REM sleep with both RA and LFO2 was attenuated with BVS (p < 0.05). We conclude that BVS leads to improvements in alveolar ventilation during sleep in this patient group.
Milross
M A
MA
Royal Prince Alfred Hospital, Camperdown, Sydney, Australia.
Piper
A J
AJ
Norman
M
M
Becker
H F
HF
Willson
G N
GN
Grunstein
R R
RR
Sullivan
C E
CE
Bye
P T
PT
D000328:Adult; D001784:Blood Gas Analysis; D003550:Cystic Fibrosis / Q000503:physiopathology* / Q000628:therapy*; D006801:Humans; D010100:Oxygen / Q000008:administration & dosage; D011659:Pulmonary Gas Exchange; D012119:Respiration; D012121:Respiration, Artificial / Q000379:methods*; D012720:Severity of Illness Index; D012890:Sleep
D010100:Oxygen